Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials
Biomolecules · 2024
DOI: 10.3390/biom14050560 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Ali I Mohammed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Dental School, Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne, Carlton, VIC 3053, Australia. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Anti-Inflammatory Agents, Chemoradiotherapy, Mucositis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mucositis is a pathological condition characterised by inflammation and ulceration of the mucous membranes lining the alimentary canal, particularly in the mouth (oral mucositis) and the gastrointestinal tract. It is a common side effect of cancer treatments, including chemotherapy and radiotherapy, and it is sometimes responsible for treatment interruptions. Preventing mucositis throughout the alimentary tract is therefore crucial. However, current interventions mainly target either oral or gastrointestinal side effects. This review aimed to investigate the use of systemically administered anti-inflammatory agents to prevent mucositis in cancer patients undergoing cancer treatment. PubMed, Ovid, Scopus, Web of Science, WHO ICTRP and ClinicalTrials.gov were screened to identify eligible randomised controlled trials (RCTs). The published literature on anti-inflammatory agents provides mixed evidence regarding the degree of efficacy in preventing/reducing the severity of mucositis in most anticancer treatments; however, sample size continued to be a significant limitation, alongside others discussed. Our review yielded a list of several anti-inflammatory agents that exhibit potential mucositis-preventive effects in cancer patients undergoing cancer treatment, which can be used to inform clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Melbourne Dental School, Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne, Carlton, VIC 3053, Australia.
- Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Department of Oral Medicine and Oral Surgery, Faculty of Dentistry, Jordan University of Science and Technology, Irbid 22110, Jordan.
- School of Dentistry, University of Jordan, Amman 11942, Jordan.
ORCID-Profile: Ali I Mohammed, Andy Xiaoqian Liu, Samar Khanna, Antonio Celentano, Mohammad S Alrashdan, Nicola Cirillo
Zitieren
APA
Mohammed, A. I., Fedoruk, L., Fisher, N., Liu, A. X., Khanna, S., Naylor, K., Gong, Z., Celentano, A., Alrashdan, M. S., & Cirillo, N. (2024). Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials. Biomolecules. https://doi.org/10.3390/biom14050560
Vancouver
Mohammed AI, Fedoruk L, Fisher N, Liu AX, Khanna S, Naylor K, et al. Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials. Biomolecules. 2024. doi:10.3390/biom14050560
BibTeX
@article{Mohammed2024,
author = {Mohammed, Ali I and Fedoruk, Lexi and Fisher, Nicholas and Liu, Andy Xiaoqian and Khanna, Samar and Naylor, Kaelan and Gong, Ziyi and Celentano, Antonio and Alrashdan, Mohammad S and Cirillo, Nicola},
title = {Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14050560}
}
EUVIMED